[1]

Du T, Tan Z.Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors[J/OL].Braz J Med Biol Res, 2014: E1[2014-09-01].http://dx.dio.org/10.1590/1414-431X20143695.[published online ahead of print Aug 22, 2014].

[2] 万圣云, 徐国纬, 潘升权, 等.下肢深静脉血栓形成的病因及诊断的研究进展[J].当代医学, 2009, 15(24): 25-26.
[3] Alaia MJ, Patel D, Levy A, et al.The Incidence of Venous Thromboembolism(VTE)-After Hip Arthroscopy[J].Bull Hosp Jt Dis, 2014, 72(2): 154-158.
[4] Cho ES, Chung JJ, Kim S, et al.CT venography for deep vein thrombosis using a low tube voltage(100 kVp) setting could increase venous enhancement and reduce the amount of administered iodine[J].Korean J Radiol, 2013, 14(2): 183-193.
[5] 田新华, 康志臣, 刘建华.分子影像学研究进展[J].中国实验诊断学, 2013, 17(8): 1543-1544.
[6] Houshmand S, Salavati A, Hess S, et al.The role of molecular imaging in diagnosis of deep vein thrombosis[J].Am J Nucl Med Mol Imaging, 2014, 4(5): 406-425.
[7] Nogami Y, Iida M, Banno K, et al.Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects[J].Anticancer Res, 2014, 34(2): 585-592.
[8]

Hess S, Madsen PH, Iversen ED, et al.Efficacy of FDG PET/CT Imaging for Venous Thromboembolic Disorders: Preliminary Results From a Prospective, Observational Pilot Study[J/OL].Clin Nucl Med, 2014[2014-09-01].http:www.ncbi.nlm.nih.gov/pubmed/?term=24999680.[published ahead of print July 3, 2014].

[9] Davidson T, Goitein O, Avigdor A, et al.18F-FDG-PET/CT for the diagnosis of tumor thrombosis[J].Isr Med Assoc J, 2009, 11(2): 69-73.
[10] Jing BB, Li YX, Zhang H, et al.Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model[J].Thromb Res, 2011, 128(5): 463-469.
[11] 郝玉美, 贺欣, 宋娜玲.靶向肿瘤新生血管整合素аVβ3受体显像研究现状及进展[J].国际放射医学核医学杂志, 2014, 38(3): 179-184.
[12] Dunzinger A, Hafner F, Piswanger-Sölkner J, et al.Acute deep venous thrombosis of the upper extremity as demonstrated by scintigraphy with 99mTc-apcitide[J].Nuklearmedizin, 2008, 47(5): N70-72.
[13] Bates SM, Lister-James J, Julian JA, et al.Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis[J].Arch Intern Med, 2003, 163(4): 452-456.
[14] Knight LC, Romano JE.Functional expression of bitistatin, a disintegrin with potential use in molecular imaging of thromboembolic disease[J].Protein Expr Purif, 2005, 39(2): 307-319.
[15] Baidoo KE, Knight LC, Lin KS, et al.Design and synthesis of a short-chain bitistatin analogue for imaging thrombi and emboli[J].Bioconjug Chem, 2004, 15(5): 1068-1075.
[16] Absar S, Kwon YM, Ahsan F.Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis[J].J Control Release, 2014, 177: 42-50.
[17] Brighton T, Janssen J, Butler SP.Aging of acute deep vein thrombosis measured by radiolabeled 99mTc-rt-PA[J].J Nucl Med, 2007, 48(6): 873-878.
[18] 文建峰, 张阁, 唐昭, 等.白介素-6及纤维蛋白质在下肢深静脉血栓中的表现及意义[J].陕西医学杂志, 2011, 40(9): 1181-1183.
[19] Starmans LW, van Duijnhoven SM, Rossin R, et al.SPECT imaging of fibrin using fibrin-binding peptides[J].Contrast Media Mol Imaging, 2013, 8(3): 229-237.
[20] Hara T, Bhayana B, Thompson B, et al.Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence[J].JACC Cardiovascular imaging, 2012, 5(6): 607-615.